Hims & Hers' Valuations Back To Earth - Robust Monetization Trends Deserve Reiterated Buy [Seeking Alpha]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Seeking Alpha
The prior lawsuit with NVO has also been resolved, with it opening up a path for new distribution partnership/Wegovy subscription program. These reasons may also be why HIMS has felt confident to offer an excellent FY2026/FY2030 guidance, with the growth deceleration already baked into its moderating valuations/stock prices. This is on top of their healthy balance sheet, allowing them embark on aggressive M&A activities and capacity/fulfillment/geographical expansions to drive renewed growth opportunities. HIMS is reiterated as a Buy following a technical bounce at $13s, albeit likely to remain volatile attributed to the elevated short interest (37.9%) and high beta (2.61x). Lemon_tm/iStock via Getty Images I previously covered Hims & Hers Health, Inc. HIMS ) in January 2026, discussing why I had cautiously upgraded the stock as a speculative Buy then, given the improved risk/reward profile after the prior selloff and the The analysis is provided exclusively for informati
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- CROX vs. CTAS: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]Yahoo! Finance
- HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law FirmGlobeNewswire
- Hims Data Breach Tests Trust As Valuation Gap Attracts Investors [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMSBusiness Wire
- Should You Buy Hims Stock Today? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 4/10/26 - Form 4
- 4/7/26 - Form 4
- 4/6/26 - Form 144
- HIMS's page on the SEC website